Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases

Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases Purpose of Review This review describes the recent progress in nuclease-based therapeutic applications for inherited heart diseases in vitro, highlights the development of the most recent genome editing technologies and discusses the associated challenges for clinical translation. Recent Findings Inherited cardiovascular disorders are passed from generation to generation. Over the past decade, considerable progress has been made in understanding the genetic basis of inherited heart diseases. The timely emergence of genome editing technologies using engineered programmable nucleases has revolutionized the basic research of inherited cardiovascular diseases and holds great promise for the development of targeted therapies. Summary The genome editing toolbox is rapidly expanding, and new tools have been recently added that significantly expand the capabilities of engineered nucleases. Newer classes of versatile engineered nucleases, such as the “base editors,” have been recently developed, offering the potential for efficient and precise therapeutic manipulation of the human genome. . . . Keywords Genome editing Base editing CRISPR/Cas9 Cardiovascular diseases Introduction that affect the electric system of the heart, causing arrhyth- mias. Clinical therapies for these inherited diseases focus on Cardiovascular diseases are the leading cause of death world- disease management without addressing the underlying genet- wide [1, 2]. According to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Cardiology Reports Springer Journals

Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases

Loading next page...
 
/lp/springer_journal/recent-progress-in-genome-editing-approaches-for-inherited-PDwIIv6O90
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Cardiology
ISSN
1523-3782
eISSN
1534-3170
D.O.I.
10.1007/s11886-018-0998-3
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review This review describes the recent progress in nuclease-based therapeutic applications for inherited heart diseases in vitro, highlights the development of the most recent genome editing technologies and discusses the associated challenges for clinical translation. Recent Findings Inherited cardiovascular disorders are passed from generation to generation. Over the past decade, considerable progress has been made in understanding the genetic basis of inherited heart diseases. The timely emergence of genome editing technologies using engineered programmable nucleases has revolutionized the basic research of inherited cardiovascular diseases and holds great promise for the development of targeted therapies. Summary The genome editing toolbox is rapidly expanding, and new tools have been recently added that significantly expand the capabilities of engineered nucleases. Newer classes of versatile engineered nucleases, such as the “base editors,” have been recently developed, offering the potential for efficient and precise therapeutic manipulation of the human genome. . . . Keywords Genome editing Base editing CRISPR/Cas9 Cardiovascular diseases Introduction that affect the electric system of the heart, causing arrhyth- mias. Clinical therapies for these inherited diseases focus on Cardiovascular diseases are the leading cause of death world- disease management without addressing the underlying genet- wide [1, 2]. According to

Journal

Current Cardiology ReportsSpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off